메뉴 건너뛰기




Volumn 26, Issue SUPPL. 4, 2008, Pages

Influenza vaccine supply: Building long-term sustainability

Author keywords

Influenza immunization; Influenza vaccine; Pandemic influenza; Pre pandemic vaccine; Seasonal influenza

Indexed keywords

INFLUENZA VACCINE;

EID: 51449123475     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.067     Document Type: Article
Times cited : (14)

References (24)
  • 1
    • 51449100932 scopus 로고    scopus 로고
    • WHO. Influenza. Fact Sheet 211. Revised 2003.
    • WHO. Influenza. Fact Sheet 211. Revised 2003.
  • 2
    • 34447559991 scopus 로고    scopus 로고
    • Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practises (ACIP)
    • Fiore A., Shay D., Haber P., Iskander J., Uyeki T., Mootrey G., et al. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practises (ACIP). MMWR 56 RR06 (2007) 1-54
    • (2007) MMWR , vol.56 , Issue.RR06 , pp. 1-54
    • Fiore, A.1    Shay, D.2    Haber, P.3    Iskander, J.4    Uyeki, T.5    Mootrey, G.6
  • 3
    • 35648955460 scopus 로고    scopus 로고
    • Influenza vaccines
    • WHO. Influenza vaccines. Weekly Epidemiol Record 80 33 (2005) 277-288
    • (2005) Weekly Epidemiol Record , vol.80 , Issue.33 , pp. 277-288
    • WHO1
  • 4
    • 51449086799 scopus 로고    scopus 로고
    • WHO. 10 things you need to know about pandemic influenza. Epidemic and Pandemic Alert and Response (EPR). 14 October 2005.
    • WHO. 10 things you need to know about pandemic influenza. Epidemic and Pandemic Alert and Response (EPR). 14 October 2005.
  • 5
    • 51449100073 scopus 로고    scopus 로고
    • WHO Immunization. Vaccines and Biologicals Epidemic and Pandemic Alert and Response. Global pandemic influenza action plan to increase vaccine supply. WHO September 2006.
    • WHO Immunization. Vaccines and Biologicals Epidemic and Pandemic Alert and Response. Global pandemic influenza action plan to increase vaccine supply. WHO September 2006.
  • 6
    • 51449107300 scopus 로고    scopus 로고
    • IFPMA Influenza Vaccine Supply International Task Force. Technical briefing for WHO Intergovernmental Meeting on sharing of influenza viruses and access to vaccines and other benefits. 20 November 2007.
    • IFPMA Influenza Vaccine Supply International Task Force. Technical briefing for WHO Intergovernmental Meeting on sharing of influenza viruses and access to vaccines and other benefits. 20 November 2007.
  • 7
    • 51449092754 scopus 로고    scopus 로고
    • IFPMA IVS ITF. Back ground paper: the link between seasonal and pandemic influenza vaccine production. 26 September 2007.
    • IFPMA IVS ITF. Back ground paper: the link between seasonal and pandemic influenza vaccine production. 26 September 2007.
  • 8
    • 25144448508 scopus 로고    scopus 로고
    • The macroepidemiology of influenza vaccination in 56 countries, 1997-2003
    • The MIV Study Group. The macroepidemiology of influenza vaccination in 56 countries, 1997-2003. Vaccine 23 (2005) 5133-5143
    • (2005) Vaccine , vol.23 , pp. 5133-5143
    • The MIV Study Group1
  • 9
    • 51449118319 scopus 로고    scopus 로고
    • Szucs T. Seasonal influenza vaccination in Europe. Presentation in the European Parliament. 3 October 2007.
    • Szucs T. Seasonal influenza vaccination in Europe. Presentation in the European Parliament. 3 October 2007.
  • 10
    • 51449096997 scopus 로고    scopus 로고
    • Infectious Disease Surveillance Center Japan. 2006/07 Influenza season, Japan. Infectious Agents Surveillance Report 2007;28(11):no. 333.
    • Infectious Disease Surveillance Center Japan. 2006/07 Influenza season, Japan. Infectious Agents Surveillance Report 2007;28(11):no. 333.
  • 11
    • 51449097879 scopus 로고    scopus 로고
    • CDC's Advisory Committee Recommends Influenza Vaccination for Children 6 Months Through 18 Years of Age. Press release, 27 February 2008.
    • CDC's Advisory Committee Recommends Influenza Vaccination for Children 6 Months Through 18 Years of Age. Press release, 27 February 2008.
  • 12
    • 51449098934 scopus 로고    scopus 로고
    • IFPMA Influenza Vaccine Supply International Task Force. Members are committed to increasing global access to potential pre-pandemic and pandemic vaccines. 27 September 2007.
    • IFPMA Influenza Vaccine Supply International Task Force. Members are committed to increasing global access to potential pre-pandemic and pandemic vaccines. 27 September 2007.
  • 13
    • 51449103303 scopus 로고    scopus 로고
    • IFPMA IVS ITF. Position statement on the building of an international stockpile of vaccines for H5N1 or other influenza viruses of pandemic potential for developing countries. 11 June 2007.
    • IFPMA IVS ITF. Position statement on the building of an international stockpile of vaccines for H5N1 or other influenza viruses of pandemic potential for developing countries. 11 June 2007.
  • 15
    • 17044380507 scopus 로고    scopus 로고
    • Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapor/97 (H5N3) vaccine: a potential priming strategy
    • Stephenson I., Bugarini R., Nicholson K., Podda A., Wood J., Zambon M., et al. Cross-reactivity to highly pathogenic avian influenza H5N1 viruses after vaccination with nonadjuvanted and MF59-adjuvanted influenza A/Duck/Singapor/97 (H5N3) vaccine: a potential priming strategy. JID 191 (2005) 1210-1215
    • (2005) JID , vol.191 , pp. 1210-1215
    • Stephenson, I.1    Bugarini, R.2    Nicholson, K.3    Podda, A.4    Wood, J.5    Zambon, M.6
  • 16
    • 51449099551 scopus 로고    scopus 로고
    • Projected supply of pandemic influenza vaccine sharply increases. WHO news release, 23 October 2007.
    • Projected supply of pandemic influenza vaccine sharply increases. WHO news release, 23 October 2007.
  • 17
    • 51449088764 scopus 로고    scopus 로고
    • Novartis Vaccines. Novartis breaks ground on state-of-the-art influenza vaccine manufacturing facility in Holly Springs, North Carolina. Press release, 23 August 2007.
    • Novartis Vaccines. Novartis breaks ground on state-of-the-art influenza vaccine manufacturing facility in Holly Springs, North Carolina. Press release, 23 August 2007.
  • 18
    • 51449112967 scopus 로고    scopus 로고
    • MedImmune. MedImmune breaks ground on new biologics manufacturing facility in Frederick, Maryland. Press release, 13 September 2006.
    • MedImmune. MedImmune breaks ground on new biologics manufacturing facility in Frederick, Maryland. Press release, 13 September 2006.
  • 19
    • 51449094708 scopus 로고    scopus 로고
    • ®. Press release, 13 June 2007.
    • ®. Press release, 13 June 2007.
  • 20
    • 51449101828 scopus 로고    scopus 로고
    • IFPMA IVS ITF. Prospect for increased vaccine production IFPMA IVS ITF perspective. Presentation to WHO Global Action Plan (GAP) Advisory Group Meeting. Geneva, 19 October 2007.
    • IFPMA IVS ITF. Prospect for increased vaccine production IFPMA IVS ITF perspective. Presentation to WHO Global Action Plan (GAP) Advisory Group Meeting. Geneva, 19 October 2007.
  • 21
    • 33645802797 scopus 로고    scopus 로고
    • Mitigation strategies for pandemic influenza in the United States
    • Germann T., Kadau K., Longini I., and Macken C. Mitigation strategies for pandemic influenza in the United States. PNAS 103 15 (2006) 5935-5940
    • (2006) PNAS , vol.103 , Issue.15 , pp. 5935-5940
    • Germann, T.1    Kadau, K.2    Longini, I.3    Macken, C.4
  • 23
    • 51449086117 scopus 로고    scopus 로고
    • WHO and manufacturers move ahead with plans for H5N1 influenza global vaccine stockpile. WHO news release, 13 June 2007.
    • WHO and manufacturers move ahead with plans for H5N1 influenza global vaccine stockpile. WHO news release, 13 June 2007.
  • 24
    • 51449099847 scopus 로고    scopus 로고
    • First pre-pandemic vaccine approved to help protect against pandemic influenza. GSK news release, 19 May 2008.
    • First pre-pandemic vaccine approved to help protect against pandemic influenza. GSK news release, 19 May 2008.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.